Development of chitosan-ellagic acid films as a local drug delivery system to induce apoptotic death of human melanoma cells.
This study was designed to develop a local chemotherapy device using chitosan as a local drug carrier and ellagic acid (EA) as an anticancer drug. We fabricated chitosan-ellagic acid (Ch-EA) films with concentrations of 0, 0.05, 0.1, 0.5, and 1% (w/v) of EA and examined the films using Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), and contact angle measurement. The WM115 human melanoma cell line as a skin cancer model was used to evaluate cell response to the films with the MTS assay and apoptosis assay, and HS68 human newborn fibroblast cell line as a control. With the increase in the concentration of the EA, the composite films exhibit increasing amide and ester groups and diffraction peaks of the crystallized EA and greater surface roughness and hydrophilicity. The chitosan films with 0.5 and 1% (w/v) of EA were found to have a potent antiproliferative effect on the melanoma cells by inducing apoptotic cell death. Localized effect of composites on cell behaviors has been clearly demonstrated. Our study demonstrated that the novel Ch-EA film can be potentially used in local chemotherapy.
Kim
Sungwoo
S
Department of Biomedical Engineering and Imaging, University of Tennessee Health Science Center, Memphis, Tennessee 31863, USA.
Liu
Yongxing
Y
Gaber
M Waleed
MW
Bumgardner
Joel D
JD
Haggard
Warren O
WO
Yang
Yunzhi
Y
D017209:Apoptosis; D002448:Cell Adhesion; D002460:Cell Line; D045744:Cell Line, Tumor; D048271:Chitosan; D016503:Drug Delivery Systems; D004610:Ellagic Acid; D005347:Fibroblasts / Q000166:cytology; D006801:Humans; D007231:Infant, Newborn; D008545:Melanoma / Q000473:pathology*; D008855:Microscopy, Electron, Scanning; D017550:Spectroscopy, Fourier Transform Infrared; D014961:X-Ray Diffraction
D004610:Ellagic Acid; D048271:Chitosan